Genome-wide Linkage and Association Analyses Implicate FASN in Predisposition to Uterine Leiomyomata

Cramer, 1990, The frequency of uterine leiomyomas, Am. J. Clin. Pathol., 94, 435, 10.1093/ajcp/94.4.435 Buttram, 1981, Uterine leiomyomata: Etiology, symptomatology, and management, Fertil. Steril., 36, 433, 10.1016/S0015-0282(16)45789-4 Lepine, 1997, Hysterectomy surveillance—United States, 1980-1993, MMWR CDC Surveill. Summ., 46, 1 Flynn, 2006, Health care resource use for uterine fibroid tumors in the United States, Am. J. Obstet. Gynecol., 195, 955, 10.1016/j.ajog.2006.02.020 Rein, 1991, Cytogenetic abnormalities in uterine leiomyomata, Obstet. Gynecol., 77, 923 Gross, 2001, Genetics and the development of fibroids, Clin. Obstet. Gynecol., 44, 335, 10.1097/00003081-200106000-00020 Brosens, 1998, Clinical significance of cytogenetic abnormalities in uterine myomas, Fertil. Steril., 69, 232, 10.1016/S0015-0282(97)00472-X Christacos, 2006, Uterine leiomyomata with deletions of Ip represent a distinct cytogenetic subgroup associated with unusual histologic features, Genes Chromosomes Cancer, 45, 304, 10.1002/gcc.20291 Huyck, 2008, The impact of race as a risk factor for symptom severity and age at diagnosis of uterine leiomyomata among affected sisters, Am J Obstet Gynecol., 198, 168.e1, 10.1016/j.ajog.2007.05.038 Marshall, 1997, Variation in the incidence of uterine leiomyoma among premenopausal women by age and race, Obstet. Gynecol., 90, 967, 10.1016/S0029-7844(97)00534-6 Vikhlyaeva, 1995, Familial predisposition to uterine leiomyomas, Int. J. Gynaecol. Obstet., 51, 127, 10.1016/0020-7292(95)02533-I Treloar, 1998, Genetic influences on the age at menopause, Lancet, 352, 1084, 10.1016/S0140-6736(05)79753-1 Luoto, 2000, Heritability and risk factors of uterine fibroids—the Finnish Twin Cohort study, Maturitas, 37, 15, 10.1016/S0378-5122(00)00160-2 Schoenberg Fejzo, 1996, Translocation breakpoints upstream of the HMGIC gene in uterine leiomyomata suggest dysregulation of this gene by a mechanism different from that in lipomas, Genes Chromosomes Cancer, 17, 1, 10.1002/(SICI)1098-2264(199609)17:1<1::AID-GCC1>3.0.CO;2-0 Hodge, 2009, Uterine leiomyomata and decreased height: A common HMGA2 predisposition allele, Hum. Genet., 125, 257, 10.1007/s00439-008-0621-6 Purcell, 2007, PLINK: A tool set for whole-genome association and population-based linkage analyses, Am. J. Hum. Genet., 81, 559, 10.1086/519795 Ridker, 2008, Rationale, design, and methodology of the Women’s Genome Health Study: a genome-wide association study of more than 25,000 initially healthy american women, Clin. Chem., 54, 249, 10.1373/clinchem.2007.099366 Medland, 2009, Common variants in the trichohyalin gene are associated with straight hair in Europeans, Am. J. Hum. Genet., 85, 750, 10.1016/j.ajhg.2009.10.009 Painter, 2011, Genome-wide association study identifies a locus at 7p15.2 associated with endometriosis, Nat. Genet., 43, 51, 10.1038/ng.731 Treloar, 2005, Genomewide linkage study in 1,176 affected sister pair families identifies a significant susceptibility locus for endometriosis on chromosome 10q26, Am. J. Hum. Genet., 77, 365, 10.1086/432960 Treloar, 1999, Predictors of hysterectomy: An Australian study, Am. J. Obstet. Gynecol., 180, 945, 10.1016/S0002-9378(99)70666-6 Kharazmi, 2007, Cardiovascular diseases attributable to hysterectomy: A population-based study, Acta Obstet. Gynecol. Scand., 86, 1476, 10.1080/00016340701698633 Takeda, 2008, Relationship between metabolic syndrome and uterine leiomyomas: A case-control study, Gynecol. Obstet. Invest., 66, 14, 10.1159/000114250 Menendez, 2007, Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis, Nat. Rev. Cancer, 7, 763, 10.1038/nrc2222 de Sousa Abreu, 2009, Global signatures of protein and mRNA expression levels, Mol. Biosyst., 5, 1512 Cha, 2011, A genome-wide association study identifies three loci associated with susceptibility to uterine fibroids, Nat. Genet., 43, 447, 10.1038/ng.805 Kusakabe, 2000, Fatty acid synthase is expressed mainly in adult hormone-sensitive cells or cells with high lipid metabolism and in proliferating fetal cells, J. Histochem. Cytochem., 48, 613, 10.1177/002215540004800505 Eberlé, 2004, SREBP transcription factors: Master regulators of lipid homeostasis, Biochimie, 86, 839, 10.1016/j.biochi.2004.09.018 Graner, 2004, The isopeptidase USP2a regulates the stability of fatty acid synthase in prostate cancer, Cancer Cell, 5, 253, 10.1016/S1535-6108(04)00055-8 Alò, 1999, Fatty acid synthase (FAS) predictive strength in poorly differentiated early breast carcinomas, Tumori, 85, 35, 10.1177/030089169908500108 Rossi, 2003, Fatty acid synthase expression defines distinct molecular signatures in prostate cancer, Mol. Cancer Res., 1, 707 Ogino, 2008, Cohort study of fatty acid synthase expression and patient survival in colon cancer, J. Clin. Oncol., 26, 5713, 10.1200/JCO.2008.18.2675 Liu, 2010, Biochemistry, molecular biology, and pharmacology of fatty acid synthase, an emerging therapeutic target and diagnosis/prognosis marker, Int J Biochem Mol Biol., 1, 69 Pizer, 1996, Inhibition of fatty acid synthesis induces programmed cell death in human breast cancer cells, Cancer Res., 56, 2745 Pizer, 1998, Pharmacological inhibitors of mammalian fatty acid synthase suppress DNA replication and induce apoptosis in tumor cell lines, Cancer Res., 58, 4611 Van de Sande, 2002, Role of the phosphatidylinositol 3′-kinase/PTEN/Akt kinase pathway in the overexpression of fatty acid synthase in LNCaP prostate cancer cells, Cancer Res., 62, 642 Porstmann, 2005, PKB/Akt induces transcription of enzymes involved in cholesterol and fatty acid biosynthesis via activation of SREBP, Oncogene, 24, 6465, 10.1038/sj.onc.1208802 Alli, 2005, Fatty acid synthase inhibitors are chemopreventive for mammary cancer in neu-N transgenic mice, Oncogene, 24, 39, 10.1038/sj.onc.1208174 Lupu, 2006, Pharmacological inhibitors of Fatty Acid Synthase (FASN)—Catalyzed endogenous fatty acid biogenesis: a new family of anti-cancer agents?, Curr. Pharm. Biotechnol., 7, 483, 10.2174/138920106779116928 Knowles, 2007, Genome-wide changes accompanying knockdown of fatty acid synthase in breast cancer, BMC Genomics, 8, 168, 10.1186/1471-2164-8-168